Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VKORC1 | Q9BQB6 | 2/20 | 0.65 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SI | P14410 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28444444 | 0.99 | VKORC1 (0.67) | VKORC1ABCG2ALOX15CYP19A1MGAM | |
| SCHEMBL28552754 | 0.99 | VKORC1 (0.67) | VKORC1ABCG2ALOX15CYP19A1MGAM | |
| SCHEMBL623887 | 0.89 | VKORC1 (0.59) | VKORC1ABCG2ALOX15CYP19A1GAA | |
| SCHEMBL27971484 | 0.88 | VKORC1 (0.51) | VKORC1ABCG2ALOX15CYP19A1MGAM | |
| SCHEMBL29699624 | 0.84 | VKORC1 (0.74) | VKORC1ABCG2ALOX15CYP19A1MGAM | |
| SCHEMBL16768172 | 0.80 | VKORC1 (0.97) | VKORC1ALOX15MGAMGAASI | |
| SCHEMBL27006404 | 0.79 | PTPN1 (0.53) | VKORC1ABCG2CYP19A1MGAMGAA | |
| SCHEMBL5309688 | 0.79 | VKORC1 (1.00) | VKORC1ALOX15MGAMGAASI | |
| SCHEMBL5309695 | 0.79 | VKORC1 (1.00) | VKORC1ALOX15MGAMGAASI | |
| SCHEMBL9019380 | 0.76 | DDR2 (0.60) | ABCG2ALOX15CYP19A1GAAPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111467391-B | Application of geranylflavone A in preparation of medicine for promoting wound healing | 汉义生物科技（北京）有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-111467391-B | Application of geranylflavone A in preparation of medicine for promoting wound healing | 汉义生物科技（北京）有限公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-114653092-A | Extraction method of industrial hemp, obtained industrial hemp essential oil and application thereof | 云南汉盟制药有限公司 | 2022-06-24 | — | — | CN | disclosed |
| US-20220079916-A1 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | HANYI BIO-TECHNOLOGY COMPANY LTD. (CN) | 2022-03-17 | — | — | US | disclosed |
| EP-3888649-A4 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | Hanyi Bio-Technology Company Ltd. (CN) | 2022-01-19 | — | — | EP | disclosed |
| CN-111956641-B | Flavonoid compound composition and preparation method thereof | 云南汉盟制药有限公司 | 2021-11-02 | — | — | CN | disclosed |
| CN-111961021-B | Separation and purification process of geranylflavone A | 云南汉盟制药有限公司 | 2021-08-03 | — | — | CN | disclosed |
| CN-111956641-A | Flavonoid compound composition and preparation method thereof | 云南汉盟制药有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-111961021-A | Separation and purification process of high-purity geranylflavonoid A | 云南汉盟制药有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-111467391-A | Application of geranylflavone A in preparation of medicine for promoting wound healing | 汉义生物科技（北京）有限公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-107987047-B | Geranylflavone compound extracted from cortex Mori, and its preparation method and application | 成都普思生物科技股份有限公司 | 2020-03-20 | — | — | CN | disclosed |
| CN-107987047-B | Geranylflavone compound extracted from cortex Mori, and its preparation method and application | 成都普思生物科技股份有限公司 | 2020-03-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220079916-A1 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | AGER, GID4, MFN2 | VKORC1 2131/4885ABCG2 3263/4885ALOX15 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.